| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Virology, December 2006, p. 11447-11455, Vol. 80, No. 23
0022-538X/06/$08.00+0 doi:10.1128/JVI.01032-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Center for Infectious Disease Research and Vaccinology, Department of Veterinary Science, South Dakota State University, Brookings, South Dakota 57007,1 Department of Diagnostic Medicine and Pathobiology, 1800 Denison Ave., Kansas State University, Manhattan, Kansas 66506,2 Boehringer Ingelheim Vetmedica, Inc., Ames, Iowa 50011,3 Animal Parasitic Diseases Laboratory, ANRI, ARS, USDA, Beltsville, Maryland 207054
Received 19 May 2006/ Accepted 4 September 2006
The recent emergence of a unique group of North American type 1 porcine reproductive and respiratory syndrome virus (PRRSV) in the United States presents new disease control problems for a swine industry that has already been impacted seriously by North American type 2 PRRSV. In this study, a full-length cDNA infectious clone was generated from a low-virulence North American type 1 PRRSV isolate, SD01-08. In vitro studies demonstrated that the cloned virus maintained growth properties similar to those of the parental virus. Virological, pathological, and immunological observations from animals challenged with cloned viruses were similar to those from animals challenged with the parental virus and a modified live virus vaccine. To further explore the potential use as a viral backbone for expressing foreign genes, the green fluorescent protein (GFP) was inserted into a unique deletion site located at amino acid positions 348 and 349 of the predicted Nsp2 region in the virus, and expression of the Nsp2-GFP fusion protein was visualized by fluorescent microscopy. The availability of this North American type 1 infectious clone provides an important research tool for further study of the basic viral biology and pathogenic mechanisms of this group of type 1 PRRSV in the United States.
Published ahead of print on 13 September 2006.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|